Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14
Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
The two rules that prevent most J1815 denials are: use the code only for injected insulin (not pump-delivered insulin), and bill units as total dose divided by 5
Storage requirements Both compounds follow standard peptide storage protocols
Comparison BPC Capsules vs
Acne involves comedones, pustules, and cysts with a different distribution pattern and different triggers
